Overview
HIT market data
Price History
HIT price chart
Valuation & Profitability
- P/E (TTM)
- 57.39 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.02 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -2.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.85 – $4.02 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $73.4M · P/B 5.29 · P/S 2.15.
Company News
Health In Tech Q2 2026 Earnings Call: Complete TranscriptBenzinga · Aug 13, 2026, 10:08 PM
8-K filing — Health In Tech, Inc. (HIT)SEC EDGAR · Aug 13, 2026, 9:17 PM
Health In Tech Affirms FY2026 Sales Guidance of $45.000M-$50.000M vs $46.813M EstBenzinga · Aug 13, 2026, 8:31 PM
Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M EstimateBenzinga · Aug 13, 2026, 8:31 PM
Health In Tech May Offer Up To $300M In Common And Preferred Stock, Warrants, Debt, Rights, And UnitsBenzinga · Jun 11, 2026, 4:35 PM
Health In Tech shares are trading lower after the company reported worse-than-expected Q1 sales results.Benzinga · May 14, 2026, 3:57 PM